8-K: Stryve Foods Adjourns Special Meeting to Solicit Additional Proxies for Key Proposals

Stryve Foods has adjourned its Special Meeting of Stockholders until January 31, 2025, to gather more proxies for Proposal 1 and Proposal 2, which are crucial for accessing additional financing.

Summary

• Stryve Foods, Inc. has adjourned its Special Meeting of Stockholders from January 10, 2025, to January 31, 2025.
• The adjournment aims to allow more time for stockholders to vote on Proposal 1 and Proposal 2, as outlined in the Definitive Proxy Statement filed on November 29, 2024.
• As of January 10, 2025, 1,967,069 shares out of 4,046,802 outstanding shares have been voted.
• Over 80% of the votes cast supported Proposal 1 and Proposal 2.
• An additional 56,333 shares need to be voted to reach the required quorum of 50% of outstanding shares.
• Approval of Proposal 1 and Proposal 2 could enable Stryve to access additional financing for general corporate purposes.
• Failure to approve the proposals may lead to additional expenses for repeated meetings and could discourage future investors.
• The reconvened Special Meeting on January 31, 2025, will be a virtual meeting conducted via live audio webcast.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company expresses optimism about accessing financing, the adjournment and need for additional votes introduce uncertainty.

Positives

• Over 80% of the shares voted so far are in favor of Proposal 1 and Proposal 2, indicating strong stockholder support.
• The company is actively seeking additional votes to reach a quorum, demonstrating a proactive approach to governance.
• Approval of the proposals could unlock access to additional financing, which would support the company's operations and growth plans.

Negatives

• The adjournment of the Special Meeting indicates difficulty in achieving a quorum, suggesting potential challenges in garnering stockholder support.
• Failure to approve Proposal 1 and Proposal 2 could lead to additional expenses and discourage future investors, potentially impacting the company's financial stability.

Risks

• The inability to secure stockholder approval for Proposal 1 and Proposal 2 could limit Stryve's ability to execute its business plan.
• Failure to raise equity capital could adversely affect the company's financial performance, growth, and ability to continue operations.
• Repeated meetings to seek stockholder approval will incur additional management resources and expenses.

Future Outlook

The company intends to use the net proceeds from the potential exercise of warrants for general corporate purposes, contingent on the approval of Proposal 1 and Proposal 2.

Management Comments

• The Board of Directors has recommended that stockholders vote FOR Proposal 1 and Proposal 2.
• We are urging all stockholders to vote immediately for Proposal 1 and Proposal 2, which could allow Stryve access to additional financing.

Industry Context

Many companies require shareholder approval for key corporate actions, and securing sufficient votes can be challenging, especially with dispersed ownership. Adjourning meetings to solicit additional proxies is a common practice.

Comparison to Industry Standards

• Achieving quorum is a standard requirement for shareholder meetings across publicly traded companies.
• Proxy solicitation and communication with shareholders are typical activities undertaken by companies to ensure sufficient participation in voting.
• Companies often engage proxy advisory firms to assist in these efforts.

Stakeholder Impact

• Shareholders are urged to vote on the proposals, as their decision will impact the company's ability to access financing.
• Employees may be affected by the company's ability to execute its business plan, which is contingent on securing additional capital.
• Future investors may be discouraged if the company fails to obtain stockholder approval, potentially impacting future financings.

Next Steps

• Stockholders who have not yet voted are encouraged to vote by following the instructions previously received.
• The reconvened Special Meeting will take place virtually on January 31, 2025.
• Stockholders can attend, vote, and submit questions during the reconvened meeting by visiting www.proxydocs.com/SNAX.

Key Dates